Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

A Case-control Study Adds a New Piece to the Aluminium/Breast Cancer Puzzle.

Mandriota SJ.

EBioMedicine. 2017 Aug;22:22-23. doi: 10.1016/j.ebiom.2017.06.025. Epub 2017 Jun 27. No abstract available.

2.

Aluminium chloride promotes tumorigenesis and metastasis in normal murine mammary gland epithelial cells.

Mandriota SJ, Tenan M, Ferrari P, Sappino AP.

Int J Cancer. 2016 Dec 15;139(12):2781-2790. doi: 10.1002/ijc.30393. Epub 2016 Sep 7.

3.

Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanism.

Mandriota SJ, Valentijn LJ, Lesne L, Betts DR, Marino D, Boudal-Khoshbeen M, London WB, Rougemont AL, Attiyeh EF, Maris JM, Hogarty MD, Koster J, Molenaar JJ, Versteeg R, Ansari M, Gumy-Pause F.

Oncotarget. 2015 Jul 30;6(21):18558-76.

4.

Aluminium chloride promotes anchorage-independent growth in human mammary epithelial cells.

Sappino AP, Buser R, Lesne L, Gimelli S, Béna F, Belin D, Mandriota SJ.

J Appl Toxicol. 2012 Mar;32(3):233-43. doi: 10.1002/jat.1793. Epub 2012 Jan 6.

PMID:
22223356
5.

The CEACAM1 tumor suppressor is an ATM and p53-regulated gene required for the induction of cellular senescence by DNA damage.

Sappino AP, Buser R, Seguin Q, Fernet M, Lesne L, Gumy-Pause F, Reith W, Favaudon V, Mandriota SJ.

Oncogenesis. 2012 Apr 16;1:e7. doi: 10.1038/oncsis.2012.7.

6.

Ataxia telangiectasia mutated (ATM) inhibition transforms human mammary gland epithelial cells.

Mandriota SJ, Buser R, Lesne L, Stouder C, Favaudon V, Maechler P, Béna F, Clément V, Rüegg C, Montesano R, Sappino AP.

J Biol Chem. 2010 Apr 23;285(17):13092-106. doi: 10.1074/jbc.M109.078360. Epub 2010 Feb 22.

7.

Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma.

Raval RR, Lau KW, Tran MG, Sowter HM, Mandriota SJ, Li JL, Pugh CW, Maxwell PH, Harris AL, Ratcliffe PJ.

Mol Cell Biol. 2005 Jul;25(13):5675-86.

8.

Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs.

Wiesener MS, Jürgensen JS, Rosenberger C, Scholze CK, Hörstrup JH, Warnecke C, Mandriota S, Bechmann I, Frei UA, Pugh CW, Ratcliffe PJ, Bachmann S, Maxwell PH, Eckardt KU.

FASEB J. 2003 Feb;17(2):271-3. Epub 2002 Dec 17.

PMID:
12490539
9.

HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron.

Mandriota SJ, Turner KJ, Davies DR, Murray PG, Morgan NV, Sowter HM, Wykoff CC, Maher ER, Harris AL, Ratcliffe PJ, Maxwell PH.

Cancer Cell. 2002 Jun;1(5):459-68.

10.

Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys.

Rosenberger C, Mandriota S, Jürgensen JS, Wiesener MS, Hörstrup JH, Frei U, Ratcliffe PJ, Maxwell PH, Bachmann S, Eckardt KU.

J Am Soc Nephrol. 2002 Jul;13(7):1721-32.

11.

Overexpression of vascular endothelial growth factor-A165 enhances tumor angiogenesis but not metastasis during beta-cell carcinogenesis.

Gannon G, Mandriota SJ, Cui L, Baetens D, Pepper MS, Christofori G.

Cancer Res. 2002 Jan 15;62(2):603-8.

12.

Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.

Tille JC, Wood J, Mandriota SJ, Schnell C, Ferrari S, Mestan J, Zhu Z, Witte L, Pepper MS.

J Pharmacol Exp Ther. 2001 Dec;299(3):1073-85.

PMID:
11714897
13.

Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis.

Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R, Banerji S, Huarte J, Montesano R, Jackson DG, Orci L, Alitalo K, Christofori G, Pepper MS.

EMBO J. 2001 Feb 15;20(4):672-82.

14.

Regulation of VEGF and VEGF receptor expression in the rodent mammary gland during pregnancy, lactation, and involution.

Pepper MS, Baetens D, Mandriota SJ, Di Sanza C, Oikemus S, Lane TF, Soriano JV, Montesano R, Iruela-Arispe ML.

Dev Dyn. 2000 Jul;218(3):507-24.

15.
16.

[Lymphangiogenesis and biological activity ov vascular endothelial growth factor-C].

Mandriota SJ, Pepper MS.

J Soc Biol. 1999;193(2):159-63. Review. French.

PMID:
10451350
17.

Multiple forms of angiostatin induce apoptosis in endothelial cells.

Lucas R, Holmgren L, Garcia I, Jimenez B, Mandriota SJ, Borlat F, Sim BK, Wu Z, Grau GE, Shing Y, Soff GA, Bouck N, Pepper MS.

Blood. 1998 Dec 15;92(12):4730-41.

18.

Both TNF receptors are required for direct TNF-mediated cytotoxicity in microvascular endothelial cells.

Lucas R, Garcia I, Donati YR, Hribar M, Mandriota SJ, Giroud C, Buurman WA, Fransen L, Suter PM, Nunez G, Pepper MS, Grau GE.

Eur J Immunol. 1998 Nov;28(11):3577-86.

20.
21.

Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells.

Olofsson B, Korpelainen E, Pepper MS, Mandriota SJ, Aase K, Kumar V, Gunji Y, Jeltsch MM, Shibuya M, Alitalo K, Eriksson U.

Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11709-14.

22.
24.

Vascular endothelial growth factor is increased in devascularized rat islets of Langerhans in vitro.

Gorden DL, Mandriota SJ, Montesano R, Orci L, Pepper MS.

Transplantation. 1997 Feb 15;63(3):436-43.

PMID:
9039936
25.

Tumor cell-conditioned medium stimulates expression of the urokinase receptor in vascular endothelial cells.

Seghezzi G, Marelli R, Mandriota SJ, Nolli ML, Mazzieri R, Mignatti P.

J Cell Physiol. 1996 Nov;169(2):300-8.

PMID:
8908197
27.

Angiogenesis-regulating cytokines: activities and interactions.

Pepper MS, Mandriota SJ, Vassalli JD, Orci L, Montesano R.

Curr Top Microbiol Immunol. 1996;213 ( Pt 2):31-67. Review. No abstract available.

PMID:
9053296
28.

Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis.

Pepper MS, Montesano R, Mandriota SJ, Orci L, Vassalli JD.

Enzyme Protein. 1996;49(1-3):138-62. Review.

PMID:
8797003
29.

Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells.

Mandriota SJ, Seghezzi G, Vassalli JD, Ferrara N, Wasi S, Mazzieri R, Mignatti P, Pepper MS.

J Biol Chem. 1995 Apr 28;270(17):9709-16.

30.

Tumor cells secrete an angiogenic factor that stimulates basic fibroblast growth factor and urokinase expression in vascular endothelial cells.

Peverali FA, Mandriota SJ, Ciana P, Marelli R, Quax P, Rifkin DB, Della Valle G, Mignatti P.

J Cell Physiol. 1994 Oct;161(1):1-14.

PMID:
7523424

Supplemental Content

Loading ...
Support Center